Microarray Scanners Market Report 2026

Microarray Scanners Market Overview

• Microarray Scanners market size has reached to $1 billion in 2025 • Expected to grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Surge In Chronic Diseases Fueling The Growth Of The Market Due To Rising Demand For Molecular Diagnostics And Biomarker Discovery • Market Trend: Innovations in Microarray Scanners MARGenomics Launches Groundbreaking Diagnostic Platform • North America was the largest region in 2025.

What Is Covered Under Microarray Scanners Market?

Microarray scanners are devices used in molecular biology and genetics research to analyze microarrays, a collection of microscopic spots containing DNA, RNA, proteins, or other molecules immobilized on a solid surface, such as a glass slide or a silicon chip. Microarray Scanners are used for measuring fluorescent regions of a DNA microarray for details about the concurrent activity of thousands of genes. The main product types of microarray scanners are fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed to detect and capture fluorescent signals emitted by fluorescently labeled molecules on microarrays. The various technologies used in microarray scanners are slide-based and gel-based, with various applications including gene expression, drug discovery, and others, and various end users including hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes.

What Is The Microarray Scanners Market Growth Forecast?

The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine research, rising investments in biotechnology and pharmaceutical R&D, expansion of large-scale genomic studies, growing integration of ai-driven data analysis, increasing demand for high-throughput research tools. Major trends in the forecast period include increasing adoption of high-resolution fluorescence scanners, rising use in genomic and proteomic research, growing integration with data analysis software, expansion of automated sample processing, enhanced focus on multiplex detection.

Global Microarray Scanners Market Segmentation

1) By Product Type: Fluorescence Microarray Scanners, Charge-Coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, Other Product Types 2) By Application: Gene Expression, Drug Discovery, Other Applications 3) By End User: Hospitals, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes Subsegments: 1) By Fluorescence Microarray Scanners: Laser Scanners, Multispectral Scanners 2) By Charge-Coupled Devices (CCD) Microarray Scanners: Standard CCD Scanners, High-Resolution CCD Scanners 3) By Colorimetric Microarray Scanners: Slide Scanners, Digital Colorimetric Scanners 4) By Other Product Types: Hybrid Scanners, Custom Or Specialized Microarray Scanners

What Is The Driver Of The Microarray Scanners Market?

The rising prevalence of chronic diseases is expected to propel the growth of the microarray scanner market going forward. Chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Microarray scanners can assess gene expression patterns, allowing researchers to investigate the molecular mechanisms underlying chronic diseases and discover potential biomarkers for diagnosis, prognosis, and treatment. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people with chronic diseases worldwide by the year 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the microarray scanner industry.

Key Players In The Global Microarray Scanners Market

Major companies operating in the microarray scanners market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation

Global Microarray Scanners Market Trends and Insights

Major companies operating in the microarray scanners market are developing innovative products, such as an advanced microarray platform, to sustain their position in the market. An advanced microarray platform is a high-throughput technology that enables simultaneous analysis of thousands of genes, proteins, or biomarkers on a single chip with enhanced sensitivity, specificity, and data accuracy. For instance, in June 2023, MARGenomics private ltd., a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform that marks a significant development in the microarray technology space. This platform is notable for being the first in Europe and the United States to receive regulatory approval for diagnostic purposes, indicating its potential impact on clinical diagnostics and research. With its ability to provide high-resolution genomic data, it is poised to enhance personalized medicine approaches in various therapeutic areas.

What Are Latest Mergers And Acquisitions In The Microarray Scanners Market?

In May 2024, New York Blood Center Enterprises (NYBCe), a US-based healthcare/biotechnology research organization, partnered with Thermo Fisher Scientific. With this partnership, the two aimed to co-develop the Applied Biosystems Axiom BloodGenomiX™ Array and Reporter Software, a next-generation, high-throughput solution for more precise blood genotyping, enhancing safety in transfusions. Thermo Fisher Scientific, a US-based technology and life sciences company.

Regional Outlook

North America was the largest region in the microarray scanners market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Microarray Scanners Market?

The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.